Decoding PRTFDC1's Role in Lung Adenocarcinoma: From GeneExpression to Clinical Implications
PRTFDC1 is a promising biomarker for LUAD prognosis and treatment response, with potential implications for targeted therapies and personalized medicine.
Authors
- Dongbing Li
- Caineng Zhong (ORCID: https://orcid.org/0009-0003-6562-0673)
- Qiang Zhang (ORCID: https://orcid.org/0009-0009-9485-6590)
- Haiyang Zhang (ORCID: https://orcid.org/0000-0002-3025-9609)
- Jian Yao (ORCID: https://orcid.org/0000-0003-4797-901X)
- Xiangcheng Lei
Institutions
- People 's Hospital of Jilin Province (CN)
- Beijing Zhongke Science and Technology (China) (CN)
- Changchun University of Chinese Medicine (CN)
Publication Details
- Journal
- Current Medicinal Chemistry
- Published
- 2025-08-22
- DOI
- https://doi.org/10.2174/0109298673367449250728104846
- Citations
- 1
- Primary Topic
- Peptidase Inhibition and Analysis
- Type
- article
- Field-Weighted Citation Impact
- 1.05